Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy

NAActive, not recruitingINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions
Pain
Interventions
PROCEDURE

Neurofeedback Training

Neurofeedback Group + Sham Neurofeedback Group: Participants participate in sessions for a minimum of 2 treatments a week for a maximum of 10 weeks for a total of 20 sessions.

PROCEDURE

Electroencephalogram

"Participants undergo an EEG at baseline, during each neurofeedback session, within 7 days of the conclusion of treatment, and again in one month.~Standard of care group receives EEG at baseline, 1 week after neurofeedback group completes sessions, and again in one month."

BEHAVIORAL

Pain Scale

Participants in neurofeedback groups asked to rate their pain on a scale of 0 (no pain) to 10 (the worst pain) prior to each session of neurofeedback, and again at the conclusion of the session.

BEHAVIORAL

Questionnaires

Seven questionnaires regarding symptoms and quality of life completed at baseline, 1 week after neurofeedback sessions, and again in one month.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Rising Tide Foundation

OTHER

lead

M.D. Anderson Cancer Center

OTHER

NCT02573766 - Neuromodulation as a Treatment for Chemotherapy-Induced Peripheral Neuropathy | Biotech Hunter | Biotech Hunter